Cargando…
Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein
Recent HIV-1 vaccine development has centered on “near native” soluble envelope glycoprotein (Env) trimers that are artificially stabilized laterally (between protomers) and apically (between gp120 and gp41). These mutations have been leveraged for use in membrane-expressed Env mRNA vaccines, althou...
Autores principales: | Tong, Tommy, D’Addabbo, Alessio, Xu, Jiamin, Chawla, Himanshi, Nguyen, Albert, Ochoa, Paola, Crispin, Max, Binley, James M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434953/ https://www.ncbi.nlm.nih.gov/pubmed/37549185 http://dx.doi.org/10.1371/journal.ppat.1011452 |
Ejemplares similares
-
Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens
por: Crooks, Emma T., et al.
Publicado: (2021) -
Principles of SARS-CoV-2 glycosylation
por: Chawla, Himanshi, et al.
Publicado: (2022) -
Exploitation of glycosylation in enveloped virus pathobiology
por: Watanabe, Yasunori, et al.
Publicado: (2019) -
Comparative Immunogenicity of Evolved V1V2-Deleted HIV-1 Envelope Glycoprotein Trimers
por: Bontjer, Ilja, et al.
Publicado: (2013) -
A Roadmap for the Molecular Farming of Viral Glycoprotein Vaccines: Engineering Glycosylation and Glycosylation-Directed Folding
por: Margolin, Emmanuel, et al.
Publicado: (2020)